| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 07/13/2005 | CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916816 Phenanthryl piperazinyl dicarboxylic acids as selective NMDA receptor modulating agents |
| 07/12/2005 | US6916805 Therapeutic agents for treating or preventing disease states in mammals characterized by abnormal thrombosis |
| 07/07/2005 | WO2005061467A2 Piperazine derivatives as bradykinin antagonists |
| 07/07/2005 | US20050148773 labeling reagents; powerful tools for analyte analysis, including but not limited to multiplex proteomic analysis; comprises one or more heavy atom isotopes; intermediates in the synthesis of active esters of N-substituted piperazine acetic acid |
| 07/07/2005 | US20050148772 Methods and compositions for detecting polynucleotide duplex damage and errors |
| 07/07/2005 | US20050148771 Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof |
| 07/07/2005 | US20050148595 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 07/07/2005 | US20050148590 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology |
| 07/07/2005 | US20050148586 Quinoxalinones |
| 07/07/2005 | US20050148572 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 07/07/2005 | DE10354860A1 Halogenierte oder pseudohalogenierte monomere Phenaziniumverbindungen, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltendes saures Bad und Verfahren zum elektrolytischen Abscheiden eines Kupferniederschlages Halogenated or pseudo-halogenated monomeric phenazinium, process for their preparation and compounds containing acidic bath and method for electrolytically depositing a copper deposit |
| 07/07/2005 | CA2529314A1 Piperazine derivatives and methods of use |
| 07/06/2005 | EP1549614A2 Vasculostatic agents and methods of use thereof |
| 07/06/2005 | EP1280809B1 Antitumoral ecteinascidin derivatives |
| 07/06/2005 | EP1140909B1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2005 | CN1635877A Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/06/2005 | CN1634896A Method for continuous synthesis of piperazine compounds by fixed bed |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058876A1 Pyrazine derivatives as effective compounds against infectious diseases |
| 06/30/2005 | WO2005058843A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/30/2005 | WO2005016277A3 Arylsulfonamidobenzylic compounds |
| 06/30/2005 | WO2004055009A8 Novel compounds having selective inhibiting efect at gsk3 |
| 06/30/2005 | WO2004055006A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143385 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/30/2005 | US20050143383 Benzo[a]phenazine-11-carboxamide derivative used as fungicide, bactericide, inhibitors of topoisomerase for treating cancer |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2548273A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/29/2005 | EP1548010A1 Process for producing oxycarbonyl-substituted piperazine derivative |
| 06/29/2005 | EP1546120A2 Pharmaceutical compositions for treatment of parkinson's disease |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP1373272B1 Tert. alkylphenoxy substituted polycyclic compounds |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 06/28/2005 | US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | CA2319554C Quinoxalinones as serine protease inhibitors such as factor xa and thrombin |
| 06/23/2005 | WO2005056547A2 Quinoxalines useful as inhibitors of protein kinases |
| 06/23/2005 | WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 06/23/2005 | WO2005033105A3 Vanilloid receptor ligands and their use in treatments |
| 06/23/2005 | WO2005025496A3 Aliphatic pyrazinoylguanidine sodium channel blockers |
| 06/23/2005 | WO2002068380A8 Synthetic excitatory amino acids |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137207 Inhibitor of prenylprotein tranferase for cancer and tumor treatment |
| 06/23/2005 | US20050137193 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; (2-phenylsulfonamidophenyl)-pyridinyl-methanones; N-[4-chloro-2(pyridine4-carbonyl)-phenyl]4-morpholin-4-yl-benzenesulfonamide |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/23/2005 | US20050137179 Potent antagonists of chemokine receptors and controls in drug screening assays; antiallergens, antiinflammatory, antifibrotic, antiarthritic, and anticarcinogenic agents; inflammatory bowel disease |
| 06/23/2005 | CA2548172A1 Quinoxalines useful as inhibitors of protein kinases |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | CN1630645A 5-HT receptor ligands and uses thereof |
| 06/22/2005 | CN1630555A Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 06/22/2005 | CN1629156A Pyrudyl and pyrimidylpiperazine derivatives, preparation method thereof and pharmaceutical composition containing the derivatives |
| 06/22/2005 | CN1629147A Pyrazinamide bulk drug and pyrazinamide tablet |
| 06/22/2005 | CN1629146A Process for synthesis of chiral 2-substituted piperazine and its derivatives |
| 06/22/2005 | CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/22/2005 | CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908919 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 06/16/2005 | WO2005054210A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | WO2005054209A1 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | WO2005054201A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | WO2005054199A1 Tubulin inhibitors |
| 06/16/2005 | US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders |
| 06/16/2005 | US20050130978 Novel crystal of quinoxalinedione derivative anhydride |
| 06/16/2005 | US20050130977 Inhibitors of akt activity |
| 06/16/2005 | CA2857067A1 Tubulin inhibitors |
| 06/16/2005 | CA2547547A1 Diazabicyclononene derivatives and their use as renin inhibitors |
| 06/16/2005 | CA2546657A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | CA2545422A1 Tubulin inhibitors |
| 06/15/2005 | EP1541563A1 Ccr4 antagonist and medicinal use thereof |
| 06/15/2005 | EP1540341A1 Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| 06/15/2005 | EP1539736A1 Substituted 1,4-pyrazine derivatives |
| 06/15/2005 | EP1539715A1 Crystal forms of quinoxaline-2-carboxylic acid 4-carbamoyl- 1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl -amide |
| 06/15/2005 | EP1539714A2 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 06/15/2005 | EP1539699A1 4- 7'-halo-2-quino (xa-) linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents |
| 06/15/2005 | EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 06/15/2005 | EP1349856B1 Isoindolin-1-one glucokinase activators |
| 06/15/2005 | EP1341764B1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
| 06/15/2005 | EP0923555B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 06/15/2005 | CN1628109A Novel aryl- and heteroarylpiperazines |
| 06/15/2005 | CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 06/15/2005 | CN1627946A Carboximide derivatives as useful uro-selective alpha-1A adrenoceptor blockers |